
Being able to boast that his country has produced the world’s first COVID-19 vaccine is just what Russian President Vladimir Putin ordered, but it remains to be seen how safe and effective the product is.
The two-dose adenovirus vaccine, which will be called Sputnik V in a throwback to the Soviet Union’s pioneering Cold War satellite program, has been developed by Moscow's Gamaleya Institute.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze